dostarlimab endometrial cancer

Keyword Analysis

Keyword	CPC	PCC	Volume	Score	Length of keyword
dostarlimab endometrial cancer	0.2	0.2	2994	85	30
dostarlimab	0.92	0.4	5442	94	11
endometrial	0.67	0.6	5401	6	11
cancer	1.26	0.6	8274	48	6

Keyword	CPC	PCC	Volume	Score
dostarlimab endometrial cancer	1.77	0.5	3074	63
dostarlimab endometrial cancer fda	1.32	0.9	4647	65
dostarlimab endometrial cancer fda approval	1.82	0.9	7855	17
dostarlimab endometrial cancer nejm	0.22	0.7	7596	83
dostarlimab endometrial cancer approval	1.98	0.5	2080	99
dostarlimab endometrial cancer nice	1.52	0.5	3775	36
dostarlimab endometrial cancer garnet	1.23	0.8	2193	29
dostarlimab and endometrial cancer	0.74	0.2	9249	43
nice dostarlimab endometrial cancer	0.85	0.6	9413	73
dostarlimab rectal cancer fda	1.75	0.9	1056	64
dostarlimab for breast cancer	1.31	0.2	7074	25
dostarlimab fda approval colon cancer	1.2	0.6	9458	29
is dostarlimab fda approved	1.27	0.3	8975	21
dostarlimab fda approval news	1.93	0.5	6084	33
dostarlimab breast cancer treatment	1.81	0.8	8665	43
dostarlimab clinical trials colon cancer	0.43	0.6	5761	64
fda approved endometrial cancer	1.05	0.6	6177	85
dostarlimab fda approval status	1.48	0.9	8895	34
dostarlimab fda approval press release	0.38	0.3	6748	24
dostarlimab for colon cancer	0.53	0.2	2106	42
dostarlimab for rectal cancer	0.84	0.9	1643	29
dostarlimab colon cancer trial	0.49	0.4	963	10
dostarlimab fda approval history	1.01	0.5	1632	57
dostarlimab for pancreatic cancer	0.93	0.7	4104	95
dostarlimab rectal cancer trial	0.94	0.3	9121	22
dostarlimab trial colorectal cancer	1.29	0.6	1358	20
does dostarlimab work on all cancers	1.54	0.7	8070	27